Zacks Investment Management increased its position in MetLife Inc. (NYSE:MET) by 3.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 388,499 shares of the company’s stock after buying an additional 13,818 shares during the period. Zacks Investment Management’s holdings in MetLife were worth $15,474,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in MET. Commonwealth Bank of Australia raised its position in shares of MetLife by 6.1% in the second quarter. Commonwealth Bank of Australia now owns 212,847 shares of the company’s stock valued at $8,480,000 after buying an additional 12,150 shares in the last quarter. Deprince Race & Zollo Inc. raised its position in shares of MetLife by 6.7% in the second quarter. Deprince Race & Zollo Inc. now owns 722,124 shares of the company’s stock valued at $28,762,000 after buying an additional 45,507 shares in the last quarter. Hermes Investment Management Ltd. raised its position in shares of MetLife by 12.3% in the second quarter. Hermes Investment Management Ltd. now owns 393,115 shares of the company’s stock valued at $15,658,000 after buying an additional 43,100 shares in the last quarter. Douglas Lane & Associates LLC raised its position in shares of MetLife by 4.6% in the second quarter. Douglas Lane & Associates LLC now owns 1,150,985 shares of the company’s stock valued at $45,844,000 after buying an additional 50,215 shares in the last quarter. Finally, RNC Capital Management LLC raised its position in shares of MetLife by 1.3% in the second quarter. RNC Capital Management LLC now owns 366,562 shares of the company’s stock valued at $14,600,000 after buying an additional 4,629 shares in the last quarter. Institutional investors own 74.50% of the company’s stock.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Shares of MetLife Inc. (NYSE:MET) traded down 0.09% during mid-day trading on Friday, reaching $53.69. 10,845,665 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $46.83 and its 200 day moving average price is $43.75. The company has a market cap of $59.01 billion, a PE ratio of 16.49 and a beta of 1.66. MetLife Inc. has a 52-week low of $35.00 and a 52-week high of $54.98.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported $1.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.04. MetLife had a net margin of 5.58% and a return on equity of 6.99%. The firm had revenue of $17.70 billion for the quarter, compared to the consensus estimate of $17.03 billion. During the same quarter in the previous year, the company earned $0.62 EPS. The company’s revenue for the quarter was down 99.9% on a year-over-year basis. On average, equities research analysts predict that MetLife Inc. will post $4.63 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Monday, November 7th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, November 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.98%. MetLife’s payout ratio is presently 49.23%.

Several brokerages recently weighed in on MET. Argus restated a “buy” rating and issued a $54.00 price objective on shares of MetLife in a report on Wednesday, September 7th. JPMorgan Chase & Co. restated a “buy” rating and issued a $51.00 price objective on shares of MetLife in a report on Friday, November 4th. FBR & Co restated a “buy” rating on shares of MetLife in a report on Thursday, November 3rd. TheStreet raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Friday, October 28th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and issued a $44.00 target price on shares of MetLife in a research note on Saturday, October 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $51.35.

In related news, EVP Frans Hijkoop sold 56,250 shares of the business’s stock in a transaction on Wednesday, November 9th. The shares were sold at an average price of $51.48, for a total transaction of $2,895,750.00. Following the transaction, the executive vice president now owns 111,813 shares in the company, valued at approximately $5,756,133.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Maria R. Morris sold 2,200 shares of the business’s stock in a transaction on Tuesday, November 1st. The shares were sold at an average price of $47.33, for a total transaction of $104,126.00. Following the transaction, the executive vice president now owns 109,809 shares in the company, valued at approximately $5,197,259.97. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

About MetLife

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

5 Day Chart for NYSE:MET

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.